A Phase I/IIa, Open-label, Non-randomized, Study of ASC-101 in Patients With Hematologic Malignancies or Myelodysplastic Syndrome (MDS) Who Are Candidates for Dual-cord Umbilical Cord Blood Transplantation (UCBT)
Status: Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 19 Mar 2015
Price : $35 *
At a glance
- Drugs TZ 101 (Primary)
- Indications Haematological malignancies; Myelodysplastic syndromes
- Focus Adverse reactions
- 19 Mar 2015 Last checked against ClinicalTrials.gov record.
- 20 Nov 2013 New source identified and integrated: ClinicalTrials.gov record.
- 09 Sep 2013 New trial record